Clinical Trial Update: Study of DTap-IPV Compared to DAPTACEL® and IPOL® as the 5th Dose in Children 4 to 6 Years of Age [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating the DTap-IPV vaccine as the fifth dose in children aged 4 to 6 years, comparing it with DAPTACEL and IPOL; results were posted in 201…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diphtheria
• Measles
• Pertussis
• Poliomyelitis
• Tetanus

Drugs mentioned

• DAPTACEL (Diphtheria Tetanus Acellular Pertussis Vaccine Adsorbed)
• DTap-IPV
• IPOL (inactivated poliovirus vaccine)

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Tetanus, Diphtheria | Phase 3 | Status: COMPLETED | Results posted: 2015-05-29